Answers are grounded in this paper and cite their sources.
Examines antimalarial resistance markers, indicating the need for therapeutic studies in Ghana.
after two decades of chloroquine disuse in Ghana suggests the return of chloroquine-sensitive parasites. Therapeutic efficacy studies must be done to verify this observation. The opposing trends of sulfadoxine-pyrimethamine molecular markers highlight concern for its use in malaria prophylaxis in pregnancy and children. Molecular surveillance remains vital to mitigating the risk of artemisinin-resistant parasites evolving in malaria-endemic regions.
No takes yet. Share an insight, caveat, or question.
Tandoh et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: